Stanhope AI

Stanhope AI is a London-based deep-tech company and spinout from University College London and King's College London, building a brain-inspired artificial intelligence framework for autonomous systems that operate in dynamic physical environments. The company's Real World Model applies the Free Energy Principle — a neuroscience framework developed by co-founder Professor Karl Friston that describes how intelligent systems minimise uncertainty through continuous perception and action — to create AI that can learn, adapt, and make decisions in real time without relying on large static datasets.

The dominant paradigm in artificial intelligence relies on large pretrained models and cloud-based processing, creating significant limitations for systems that must operate in unpredictable real-world conditions. Autonomous drones, robotics platforms, and industrial equipment require AI that can adapt on the fly — updating its behaviour as conditions change, rather than relying on precomputed assumptions. Stanhope AI addresses this through Active Inference, allowing its models to run efficiently on-device using minimal data and energy, enabling reliable operation in communications-denied environments or embedded systems where cloud connectivity is unavailable.

Stanhope AI's technology is being tested in autonomous drone and robotics applications with international partners including Germany's Federal Agency for Disruptive Innovation and the Royal Navy. Target verticals include defence and aerospace, autonomous vehicles, industrial automation, and embedded devices — sectors where reliability under uncertain conditions is mission-critical. The system's ability to function without GPS, mapping systems, or expensive human operators sets it apart from conventional autonomous AI approaches.

The company raised £2.3 million in March 2024 led by UCL Technology Fund, then closed a £6 million seed round in February 2026 led by Frontline Ventures, with participation from Paladin Capital Group, Auxxo Female Catalyst Fund, and follow-on investment from UCL Technology Fund and MMC Ventures. The new capital will fund scale-up of partnerships and expansion of field trials across multiple sectors through 2026.